Global Retinal Drugs and Biologics Market Insights, Forecast to 2029

Global Retinal Drugs and Biologics Market Insights, Forecast to 2029

Table of Contents
1 Study Coverage
1.1 Retinal Drugs and Biologics Product Introduction
1.2 Market by Type
1.2.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Age Related Macular Degeneration
1.2.3 Diabetic Retinopathy
1.2.4 Ocular Inflammatory Disease (Uveitis)
1.2.5 Macular Hole
1.3 Market by Application
1.3.1 Global Retinal Drugs and Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Retinal Drugs and Biologics Sales Estimates and Forecasts 2018-2029
2.2 Global Retinal Drugs and Biologics Revenue by Region
2.2.1 Global Retinal Drugs and Biologics Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Retinal Drugs and Biologics Revenue by Region (2018-2023)
2.2.3 Global Retinal Drugs and Biologics Revenue by Region (2024-2029)
2.2.4 Global Retinal Drugs and Biologics Revenue Market Share by Region (2018-2029)
2.3 Global Retinal Drugs and Biologics Sales Estimates and Forecasts 2018-2029
2.4 Global Retinal Drugs and Biologics Sales by Region
2.4.1 Global Retinal Drugs and Biologics Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Retinal Drugs and Biologics Sales by Region (2018-2023)
2.4.3 Global Retinal Drugs and Biologics Sales by Region (2024-2029)
2.4.4 Global Retinal Drugs and Biologics Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Retinal Drugs and Biologics Sales by Manufacturers
3.1.1 Global Retinal Drugs and Biologics Sales by Manufacturers (2018-2023)
3.1.2 Global Retinal Drugs and Biologics Sales Market Share by Manufacturers (2018-2023)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Retinal Drugs and Biologics in 2022
3.2 Global Retinal Drugs and Biologics Revenue by Manufacturers
3.2.1 Global Retinal Drugs and Biologics Revenue by Manufacturers (2018-2023)
3.2.2 Global Retinal Drugs and Biologics Revenue Market Share by Manufacturers (2018-2023)
3.2.3 Global Top 10 and Top 5 Companies by Retinal Drugs and Biologics Revenue in 2022
3.3 Global Key Players of Retinal Drugs and Biologics, Industry Ranking, 2021 VS 2022 VS 2023
3.4 Global Retinal Drugs and Biologics Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Retinal Drugs and Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Retinal Drugs and Biologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Retinal Drugs and Biologics, Product Offered and Application
3.8 Global Key Manufacturers of Retinal Drugs and Biologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Retinal Drugs and Biologics Sales by Type
4.1.1 Global Retinal Drugs and Biologics Historical Sales by Type (2018-2023)
4.1.2 Global Retinal Drugs and Biologics Forecasted Sales by Type (2024-2029)
4.1.3 Global Retinal Drugs and Biologics Sales Market Share by Type (2018-2029)
4.2 Global Retinal Drugs and Biologics Revenue by Type
4.2.1 Global Retinal Drugs and Biologics Historical Revenue by Type (2018-2023)
4.2.2 Global Retinal Drugs and Biologics Forecasted Revenue by Type (2024-2029)
4.2.3 Global Retinal Drugs and Biologics Revenue Market Share by Type (2018-2029)
4.3 Global Retinal Drugs and Biologics Price by Type
4.3.1 Global Retinal Drugs and Biologics Price by Type (2018-2023)
4.3.2 Global Retinal Drugs and Biologics Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Retinal Drugs and Biologics Sales by Application
5.1.1 Global Retinal Drugs and Biologics Historical Sales by Application (2018-2023)
5.1.2 Global Retinal Drugs and Biologics Forecasted Sales by Application (2024-2029)
5.1.3 Global Retinal Drugs and Biologics Sales Market Share by Application (2018-2029)
5.2 Global Retinal Drugs and Biologics Revenue by Application
5.2.1 Global Retinal Drugs and Biologics Historical Revenue by Application (2018-2023)
5.2.2 Global Retinal Drugs and Biologics Forecasted Revenue by Application (2024-2029)
5.2.3 Global Retinal Drugs and Biologics Revenue Market Share by Application (2018-2029)
5.3 Global Retinal Drugs and Biologics Price by Application
5.3.1 Global Retinal Drugs and Biologics Price by Application (2018-2023)
5.3.2 Global Retinal Drugs and Biologics Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Retinal Drugs and Biologics Market Size by Type
6.1.1 US & Canada Retinal Drugs and Biologics Sales by Type (2018-2029)
6.1.2 US & Canada Retinal Drugs and Biologics Revenue by Type (2018-2029)
6.2 US & Canada Retinal Drugs and Biologics Market Size by Application
6.2.1 US & Canada Retinal Drugs and Biologics Sales by Application (2018-2029)
6.2.2 US & Canada Retinal Drugs and Biologics Revenue by Application (2018-2029)
6.3 US & Canada Retinal Drugs and Biologics Market Size by Country
6.3.1 US & Canada Retinal Drugs and Biologics Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Retinal Drugs and Biologics Sales by Country (2018-2029)
6.3.3 US & Canada Retinal Drugs and Biologics Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Retinal Drugs and Biologics Market Size by Type
7.1.1 Europe Retinal Drugs and Biologics Sales by Type (2018-2029)
7.1.2 Europe Retinal Drugs and Biologics Revenue by Type (2018-2029)
7.2 Europe Retinal Drugs and Biologics Market Size by Application
7.2.1 Europe Retinal Drugs and Biologics Sales by Application (2018-2029)
7.2.2 Europe Retinal Drugs and Biologics Revenue by Application (2018-2029)
7.3 Europe Retinal Drugs and Biologics Market Size by Country
7.3.1 Europe Retinal Drugs and Biologics Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Retinal Drugs and Biologics Sales by Country (2018-2029)
7.3.3 Europe Retinal Drugs and Biologics Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Retinal Drugs and Biologics Market Size
8.1.1 China Retinal Drugs and Biologics Sales (2018-2029)
8.1.2 China Retinal Drugs and Biologics Revenue (2018-2029)
8.2 China Retinal Drugs and Biologics Market Size by Application
8.2.1 China Retinal Drugs and Biologics Sales by Application (2018-2029)
8.2.2 China Retinal Drugs and Biologics Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Retinal Drugs and Biologics Market Size by Type
9.1.1 Asia Retinal Drugs and Biologics Sales by Type (2018-2029)
9.1.2 Asia Retinal Drugs and Biologics Revenue by Type (2018-2029)
9.2 Asia Retinal Drugs and Biologics Market Size by Application
9.2.1 Asia Retinal Drugs and Biologics Sales by Application (2018-2029)
9.2.2 Asia Retinal Drugs and Biologics Revenue by Application (2018-2029)
9.3 Asia Retinal Drugs and Biologics Sales by Region
9.3.1 Asia Retinal Drugs and Biologics Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Retinal Drugs and Biologics Revenue by Region (2018-2029)
9.3.3 Asia Retinal Drugs and Biologics Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Retinal Drugs and Biologics Market Size by Type
10.1.1 Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Retinal Drugs and Biologics Market Size by Application
10.2.1 Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Country
10.3.1 Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 ALLERGAN
11.1.1 ALLERGAN Company Information
11.1.2 ALLERGAN Overview
11.1.3 ALLERGAN Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.1.4 ALLERGAN Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 ALLERGAN Recent Developments
11.2 AbbVie
11.2.1 AbbVie Company Information
11.2.2 AbbVie Overview
11.2.3 AbbVie Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.2.4 AbbVie Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 AbbVie Recent Developments
11.3 Alimera Sciences
11.3.1 Alimera Sciences Company Information
11.3.2 Alimera Sciences Overview
11.3.3 Alimera Sciences Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.3.4 Alimera Sciences Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Alimera Sciences Recent Developments
11.4 Janssen Biotech
11.4.1 Janssen Biotech Company Information
11.4.2 Janssen Biotech Overview
11.4.3 Janssen Biotech Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.4.4 Janssen Biotech Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Janssen Biotech Recent Developments
11.5 Swedish Orphan Biovitrum
11.5.1 Swedish Orphan Biovitrum Company Information
11.5.2 Swedish Orphan Biovitrum Overview
11.5.3 Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.5.4 Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Swedish Orphan Biovitrum Recent Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Overview
11.6.3 Roche Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.6.4 Roche Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Roche Recent Developments
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Information
11.7.2 Bristol-Myers Squibb Overview
11.7.3 Bristol-Myers Squibb Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.7.4 Bristol-Myers Squibb Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol-Myers Squibb Recent Developments
11.8 Genzyme
11.8.1 Genzyme Company Information
11.8.2 Genzyme Overview
11.8.3 Genzyme Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.8.4 Genzyme Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Genzyme Recent Developments
11.9 Genentech
11.9.1 Genentech Company Information
11.9.2 Genentech Overview
11.9.3 Genentech Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.9.4 Genentech Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Genentech Recent Developments
11.10 OCULAR THERAPEUTIX
11.10.1 OCULAR THERAPEUTIX Company Information
11.10.2 OCULAR THERAPEUTIX Overview
11.10.3 OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.10.4 OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 OCULAR THERAPEUTIX Recent Developments
11.11 Bausch & Lomb
11.11.1 Bausch & Lomb Company Information
11.11.2 Bausch & Lomb Overview
11.11.3 Bausch & Lomb Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.11.4 Bausch & Lomb Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Bausch & Lomb Recent Developments
11.12 UCBCares
11.12.1 UCBCares Company Information
11.12.2 UCBCares Overview
11.12.3 UCBCares Retinal Drugs and Biologics Sales, Price, Revenue and Gross Margin (2018-2023)
11.12.4 UCBCares Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 UCBCares Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Retinal Drugs and Biologics Industry Chain Analysis
12.2 Retinal Drugs and Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Retinal Drugs and Biologics Production Mode & Process
12.4 Retinal Drugs and Biologics Sales and Marketing
12.4.1 Retinal Drugs and Biologics Sales Channels
12.4.2 Retinal Drugs and Biologics Distributors
12.5 Retinal Drugs and Biologics Customers
13 Market Dynamics
13.1 Retinal Drugs and Biologics Industry Trends
13.2 Retinal Drugs and Biologics Market Drivers
13.3 Retinal Drugs and Biologics Market Challenges
13.4 Retinal Drugs and Biologics Market Restraints
14 Key Findings in The Global Retinal Drugs and Biologics Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Retinal Drugs and Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Age Related Macular Degeneration
Table 3. Major Manufacturers of Diabetic Retinopathy
Table 4. Major Manufacturers of Ocular Inflammatory Disease (Uveitis)
Table 5. Major Manufacturers of Macular Hole
Table 6. Global Retinal Drugs and Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Retinal Drugs and Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 9. Global Retinal Drugs and Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Retinal Drugs and Biologics Revenue Market Share by Region (2018-2023)
Table 11. Global Retinal Drugs and Biologics Revenue Market Share by Region (2024-2029)
Table 12. Global Retinal Drugs and Biologics Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Retinal Drugs and Biologics Sales by Region (2018-2023) & (K MT)
Table 14. Global Retinal Drugs and Biologics Sales by Region (2024-2029) & (K MT)
Table 15. Global Retinal Drugs and Biologics Sales Market Share by Region (2018-2023)
Table 16. Global Retinal Drugs and Biologics Sales Market Share by Region (2024-2029)
Table 17. Global Retinal Drugs and Biologics Sales by Manufacturers (2018-2023) & (K MT)
Table 18. Global Retinal Drugs and Biologics Sales Share by Manufacturers (2018-2023)
Table 19. Global Retinal Drugs and Biologics Revenue by Manufacturers (2018-2023) & (US$ Million)
Table 20. Global Retinal Drugs and Biologics Revenue Share by Manufacturers (2018-2023)
Table 21. Global Key Players of Retinal Drugs and Biologics, Industry Ranking, 2021 VS 2022 VS 2023
Table 22. Retinal Drugs and Biologics Price by Manufacturers 2018-2023 (USD/MT)
Table 23. Global Retinal Drugs and Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Retinal Drugs and Biologics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Drugs and Biologics as of 2022)
Table 25. Global Key Manufacturers of Retinal Drugs and Biologics, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Retinal Drugs and Biologics, Product Offered and Application
Table 27. Global Key Manufacturers of Retinal Drugs and Biologics, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 30. Global Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 31. Global Retinal Drugs and Biologics Sales Share by Type (2018-2023)
Table 32. Global Retinal Drugs and Biologics Sales Share by Type (2024-2029)
Table 33. Global Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 34. Global Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Retinal Drugs and Biologics Revenue Share by Type (2018-2023)
Table 36. Global Retinal Drugs and Biologics Revenue Share by Type (2024-2029)
Table 37. Retinal Drugs and Biologics Price by Type (2018-2023) & (USD/MT)
Table 38. Global Retinal Drugs and Biologics Price Forecast by Type (2024-2029) & (USD/MT)
Table 39. Global Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 40. Global Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 41. Global Retinal Drugs and Biologics Sales Share by Application (2018-2023)
Table 42. Global Retinal Drugs and Biologics Sales Share by Application (2024-2029)
Table 43. Global Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 44. Global Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Retinal Drugs and Biologics Revenue Share by Application (2018-2023)
Table 46. Global Retinal Drugs and Biologics Revenue Share by Application (2024-2029)
Table 47. Retinal Drugs and Biologics Price by Application (2018-2023) & (USD/MT)
Table 48. Global Retinal Drugs and Biologics Price Forecast by Application (2024-2029) & (USD/MT)
Table 49. US & Canada Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 50. US & Canada Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 51. US & Canada Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 52. US & Canada Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 54. US & Canada Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 55. US & Canada Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 56. US & Canada Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Retinal Drugs and Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 59. US & Canada Retinal Drugs and Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Retinal Drugs and Biologics Sales by Country (2018-2023) & (K MT)
Table 61. US & Canada Retinal Drugs and Biologics Sales by Country (2024-2029) & (K MT)
Table 62. Europe Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 63. Europe Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 64. Europe Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 65. Europe Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 67. Europe Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 68. Europe Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 69. Europe Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Retinal Drugs and Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 72. Europe Retinal Drugs and Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Retinal Drugs and Biologics Sales by Country (2018-2023) & (K MT)
Table 74. Europe Retinal Drugs and Biologics Sales by Country (2024-2029) & (K MT)
Table 75. China Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 76. China Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 77. China Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 78. China Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 80. China Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 81. China Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 82. China Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 84. Asia Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 85. Asia Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 86. Asia Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 88. Asia Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 89. Asia Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 90. Asia Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Retinal Drugs and Biologics Revenue by Region (2018-2023) & (US$ Million)
Table 93. Asia Retinal Drugs and Biologics Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Retinal Drugs and Biologics Sales by Region (2018-2023) & (K MT)
Table 95. Asia Retinal Drugs and Biologics Sales by Region (2024-2029) & (K MT)
Table 96. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Type (2018-2023) & (K MT)
Table 97. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Type (2024-2029) & (K MT)
Table 98. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Type (2018-2023) & (US$ Million)
Table 99. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Application (2018-2023) & (K MT)
Table 101. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Application (2024-2029) & (K MT)
Table 102. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Application (2018-2023) & (US$ Million)
Table 103. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Country (2018-2023) & (US$ Million)
Table 106. Middle East, Africa and Latin America Retinal Drugs and Biologics Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Country (2018-2023) & (K MT)
Table 108. Middle East, Africa and Latin America Retinal Drugs and Biologics Sales by Country (2024-2029) & (K MT)
Table 109. ALLERGAN Company Information
Table 110. ALLERGAN Description and Major Businesses
Table 111. ALLERGAN Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. ALLERGAN Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. ALLERGAN Recent Developments
Table 114. AbbVie Company Information
Table 115. AbbVie Description and Major Businesses
Table 116. AbbVie Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. AbbVie Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. AbbVie Recent Developments
Table 119. Alimera Sciences Company Information
Table 120. Alimera Sciences Description and Major Businesses
Table 121. Alimera Sciences Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. Alimera Sciences Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Alimera Sciences Recent Developments
Table 124. Janssen Biotech Company Information
Table 125. Janssen Biotech Description and Major Businesses
Table 126. Janssen Biotech Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. Janssen Biotech Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Janssen Biotech Recent Developments
Table 129. Swedish Orphan Biovitrum Company Information
Table 130. Swedish Orphan Biovitrum Description and Major Businesses
Table 131. Swedish Orphan Biovitrum Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 132. Swedish Orphan Biovitrum Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Swedish Orphan Biovitrum Recent Developments
Table 134. Roche Company Information
Table 135. Roche Description and Major Businesses
Table 136. Roche Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 137. Roche Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Roche Recent Developments
Table 139. Bristol-Myers Squibb Company Information
Table 140. Bristol-Myers Squibb Description and Major Businesses
Table 141. Bristol-Myers Squibb Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 142. Bristol-Myers Squibb Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Bristol-Myers Squibb Recent Developments
Table 144. Genzyme Company Information
Table 145. Genzyme Description and Major Businesses
Table 146. Genzyme Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 147. Genzyme Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. Genzyme Recent Developments
Table 149. Genentech Company Information
Table 150. Genentech Description and Major Businesses
Table 151. Genentech Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 152. Genentech Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 153. Genentech Recent Developments
Table 154. OCULAR THERAPEUTIX Company Information
Table 155. OCULAR THERAPEUTIX Description and Major Businesses
Table 156. OCULAR THERAPEUTIX Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 157. OCULAR THERAPEUTIX Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 158. OCULAR THERAPEUTIX Recent Developments
Table 159. Bausch & Lomb Company Information
Table 160. Bausch & Lomb Description and Major Businesses
Table 161. Bausch & Lomb Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 162. Bausch & Lomb Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 163. Bausch & Lomb Recent Developments
Table 164. UCBCares Company Information
Table 165. UCBCares Description and Major Businesses
Table 166. UCBCares Retinal Drugs and Biologics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
Table 167. UCBCares Retinal Drugs and Biologics Product Model Numbers, Pictures, Descriptions and Specifications
Table 168. UCBCares Recent Developments
Table 169. Key Raw Materials Lists
Table 170. Raw Materials Key Suppliers Lists
Table 171. Retinal Drugs and Biologics Distributors List
Table 172. Retinal Drugs and Biologics Customers List
Table 173. Retinal Drugs and Biologics Market Trends
Table 174. Retinal Drugs and Biologics Market Drivers
Table 175. Retinal Drugs and Biologics Market Challenges
Table 176. Retinal Drugs and Biologics Market Restraints
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Retinal Drugs and Biologics Product Picture
Figure 2. Global Retinal Drugs and Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Retinal Drugs and Biologics Market Share by Type in 2022 & 2029
Figure 4. Age Related Macular Degeneration Product Picture
Figure 5. Diabetic Retinopathy Product Picture
Figure 6. Ocular Inflammatory Disease (Uveitis) Product Picture
Figure 7. Macular Hole Product Picture
Figure 8. Global Retinal Drugs and Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Retinal Drugs and Biologics Market Share by Application in 2022 & 2029
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Retinal Drugs and Biologics Report Years Considered
Figure 14. Global Retinal Drugs and Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Retinal Drugs and Biologics Revenue 2018-2029 (US$ Million)
Figure 16. Global Retinal Drugs and Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Glob

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs